Sign in
8-K

Current Report

Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-21-280729

Material agreement · Bylaws or fiscal year change

  • Item 1.01 Entry into a material definitive agreement
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year

From the SEC's structured data for this filing

Loading d208955d8k.htm…